| SKU | ISG001790 |
| Brand | Feburic |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 80 Mg |
| Shop by Concerns | Gout |
| Gender | Neutral |
| Shop By Goals | Gout Management |
| Ingredient | Febuxostat |
| Product Form | Tablets |
| Specialty | Clinically Tested Prescription only |
| Sub Categories | Gout Medicines |
| Unit Count | 30 Tablets |
| Warning | May Increase Risk of Suicidal Thoughts Monitor liver function and uric acid levels regularly Not recommended with certain medications Use under medical supervision only |
Feburic 80 Mg 30 Tablets
Description:
Feburic 80 mg 30 tablets is a prescription oral medicine containing febuxostat, used to lower high uric acid levels in the blood in patients with gout and chronic hyperuricaemia. It belongs to the class of xanthine oxidase inhibitors and works by reducing the production of uric acid, helping to prevent urate crystal deposition in the joints and tissues. Feburic 80 mg is typically used as long-term urate-lowering therapy in adults where urate deposition (tophi or gouty arthritis) has already occurred.
Indications:
- Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (e.g., presence of tophi, history of gouty arthritis).
- Long-term management of gout in adults by maintaining reduced serum uric acid levels.
- Helps prevent recurrent gout attacks, joint pain, redness, swelling, and stiffness associated with elevated uric acid.
- Reduction of urate crystal deposition in joints and soft tissues, helping to protect joint function over time.
Active Ingredients / Key Components:
- Febuxostat – 80 mg per film-coated tablet.
- Excipients: Full list of inactive ingredients (tablet core and film coating) is not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.). Please refer to the official package leaflet for complete excipient details.
Dosage & Administration / How to Use:
- Adults: The usual recommended dose is 1 tablet (80 mg) once daily, as indicated in the provided context.
- Tablets may be taken with or without food, swallowed whole with a glass of water. Do not crush or chew.
- Use as long-term urate-lowering therapy as directed by your physician; do not stop treatment without medical advice, even if you are symptom-free.
- Your doctor may adjust the dose or treatment duration based on serum uric acid levels, response to therapy, and overall clinical condition.
- In patients with severe renal or hepatic impairment, dose adjustment or special monitoring may be required; follow physician instructions strictly.
- If you miss a dose, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and continue with your regular schedule. Do not double the dose.
- Always follow your doctor’s instructions and the patient information leaflet. Do not exceed the prescribed dose.
Clinical Benefits:
- Effectively lowers serum uric acid levels by inhibiting xanthine oxidase, the enzyme responsible for uric acid production.
- Helps prevent recurrent gout attacks and reduces the frequency and severity of joint pain, redness, and swelling.
- Supports long-term protection of joints and tissues by limiting urate crystal formation and deposition.
- Provides a once-daily oral regimen, improving convenience and adherence for chronic gout management.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity to febuxostat or any of the excipients in the formulation.
- Not recommended in patients being treated with azathioprine, mercaptopurine, or theophylline unless under strict specialist supervision, due to potential serious interactions.
- Use with caution in patients with a history of cardiovascular disease (e.g., heart attack, stroke) as some studies have reported an increased risk of cardiovascular events with febuxostat. Discuss risks and benefits with your doctor.
- Use with caution in patients with severe renal or hepatic impairment; dose adjustment and close monitoring may be required.
- Acute gout flares may occur at the start of treatment as uric acid levels change. Your doctor may prescribe additional medicines (e.g., NSAIDs or colchicine) to prevent or manage flares.
- Discontinue treatment and seek medical attention immediately if you experience signs of severe allergic reactions such as rash, itching, swelling of the face or throat, difficulty breathing, or severe skin reactions.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Febuxostat should only be used if clearly needed and prescribed by a physician.
- Inform your doctor about all medications and supplements you are taking, especially immunosuppressants, anticoagulants, and other gout therapies.
- Do not use this medicine in children and adolescents unless specifically prescribed, as safety and efficacy data may be limited.
- Consult your doctor before use if you have a history of liver disease, kidney disease, thyroid disorders, or major cardiovascular conditions.
- Keep out of reach of children.
Side Effects:
- Common side effects may include headache, nausea, diarrhea, joint pain, mild rash, or abnormal liver function tests.
- Less common side effects can include dizziness, fatigue, swelling (edema), or gastrointestinal discomfort.
- Serious side effects (seek immediate medical attention) may include severe skin reactions (Stevens–Johnson syndrome, toxic epidermal necrolysis), signs of liver problems (yellowing of skin or eyes, dark urine, persistent nausea), chest pain, shortness of breath, sudden weakness, or speech difficulties suggestive of cardiovascular events.
- If you notice any unusual or persistent symptoms, or if side effects worsen, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Store at or below the temperature specified on the pack (refer to the product carton or leaflet for exact storage temperature if available).
Specifications:
- Form: Film-coated tablets.
- Strength: 80 mg febuxostat per tablet.
- Pack size: 30 tablets per pack.
- Route of administration: Oral.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.


